Cannabis as a Treatment for Cirrhosis
One in 400 people aged 45 to 54 that live in the United States has cirrhosis, meaning that their liver is scarred. Cirrhosis is considered a progressive, chronic disease, and results in the loss of function of the liver. The liver begins to fail when dead tissue starts to replace healthy liver tissue, resulting in cirrhosis, which is usually fatal. In contrast to other diseases, the symptoms of cirrhosis don’t appear until the liver has sustained significant damage. Medical cannabis may help prevent the occurrence of one of the more common causes of cirrhosis in people with alcoholism and diabetes type 2 because it may help with one of the causes of cirrhosis:
A paper titled “The Role of Cannabinoids in the Setting of Cirrhosis” was published in the journal Medicines in 2018. There has been a rise in the recreational and therapeutic uses of cannabis recently. This necessitates the need to investigate the potential anti-fibrogenic and profibrogenic functions of the endocannabinoid system that may help treat this condition.
Cirrhosis and Its Effects
Cirrhosis occurs when the liver has been overused by alcohol, causing it to create scar tissue. This is the cause of cirrhosis, according to the Mayo Clinic. Some diseases can remain undetected for an extended period and can cause considerable damage and sometimes result in irreversible damage before being detected. Fatigue is an early warning indicator that can help you spot the disease earlier. This is also true of bleeding and bruising, and jaundice, spider veins, confusion, and edema, all of which can be spotted with ease.
Alcoholism is one of the major causes of cirrhosis. However, other factors may also contribute to this disease, including hepatitis B, C, and D, cystic fibrosis, syphilis, and methotrexate or isoniazid use. The risk of obesity is also an extremely crucial factor to consider. To avoid contracting hepatitis B and C, a patient must abstain from alcohol use, maintain a healthy weight, and refrain from sharing needles with others
For the treatment of cirrhosis
The British Journal of Pharmacology published research 12 years ago that emphasized CB2 receptors play a vital role in the regulation of inflammation and pain in the body, as well as the regulation of atherosclerosis and osteoporosis. It was later confirmed throughout the next decade that CBD had anti-inflammatory effects through research, study, and trials.
According to research conducted by the Viral Hepatitis Center at the University of California, Los Angeles (UCLA), Dr. Norah Terrault confirmed the conclusive evidence in an interview with MD Magazine at the annual American Association for the Study of Liver Diseases conference in 2018.
Dr. Terrault says The findings are based on the understanding that when liver fibrosis occurs, cannabinoid receptors are expressed, as well as cannabinoid receptors are present in fibrotic tissue. Dr. Terrence Bukong from the University of Massachusetts Medical School told Healthline that on the question of whether cannabis use affects liver disease, the jury is still out. The same was found in a report for 2019 by Healthline, which cited Dr. Bukong from the University of Massachusetts. According to the physician’s study team, cannabis anti-inflammatory chemicals have been proven to heal wounds in an uncontroversial manner.
The findings of our study reveal that cannabis consumers have a decreased risk of alcoholic liver disease, and cannabis dependents have the lowest risk of such a disease,” he said. In addition, he said that his team plans to continue to research the therapeutic value of cannabis for specific liver disorders in the future.